Four novel mutations in the N-acetylgalactosamine-6-sulfate sulfatase gene among Egyptian patients with Morquio A disease
- PMID: 27825773
- DOI: 10.1016/j.gene.2016.11.002
Four novel mutations in the N-acetylgalactosamine-6-sulfate sulfatase gene among Egyptian patients with Morquio A disease
Abstract
Morquio A disease (Mucopolysaccharidosis IVA, MPS IVA) is an autosomal recessive lysosomal storage disorder caused by deficient activity of the enzyme N-acetylgalactosamine-6-sulfate sulfatase (GALNS) encoded by the GALNS gene. This deficiency leads to a decreased ability to degrade the glycosaminoglycans (GAGs) keratan sulfate and chondroitin 6-sulfate, thereby causing their accumulation within the lysosomes and consequently prominent skeletal and visceral abnormalities. Clinical evaluation and biochemical GALNS enzyme activity determination were carried out for the patients from four unrelated Egyptian families. Mutational analysis was performed to PCR products by sequencing of the 14 exons and exon-intron boundaries of GALNS gene for the 4 patients. Sequence analysis revealed four novel mutations; three nonsense mutations (p.Q12X, p.Q220X, p.Y254X) and one missense mutation, p.D40G. All four patients were offspring of consanguineous marriages and were homozygous for the corresponding mutation. The activity of the GALNS enzyme was below normal reference range in all of them. The p.Q12X and p.Y254X were associated with severe MPS IVA phenotype. Molecular analysis of GALNS gene revealed four novel mutations in four different Morquio A Egyptian patients.
Keywords: Egyptian; GALNS; MPS IVA; Morquio; Mucopolysaccharidosis IV A; Mutation.
Copyright © 2016 Elsevier B.V. All rights reserved.
Similar articles
-
Mucopolysaccharidosis type IV: N-acetylgalactosamine-6-sulfatase mutations in Tunisian patients.Mol Genet Metab. 2006 Mar;87(3):213-8. doi: 10.1016/j.ymgme.2005.11.001. Mol Genet Metab. 2006. PMID: 16378744
-
Molecular analysis of Turkish mucopolysaccharidosis IVA (Morquio A) patients: identification of novel mutations in the N-acetylgalactosamine-6-sulfate sulfatase (GALNS) gene.Hum Mutat. 2002 Dec;20(6):477-8. doi: 10.1002/humu.9088. Hum Mutat. 2002. PMID: 12442278
-
Mutations and polymorphisms in N-acetylgalactosamine-6-sulfate sulfatase gene in Turkish Morquio A patients.Pathol Biol (Paris). 2014 Feb;62(1):38-40. doi: 10.1016/j.patbio.2013.10.001. Epub 2014 Jan 9. Pathol Biol (Paris). 2014. PMID: 24411403
-
Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA.Mol Genet Metab. 2013 Sep-Oct;110(1-2):54-64. doi: 10.1016/j.ymgme.2013.04.002. Epub 2013 Apr 10. Mol Genet Metab. 2013. PMID: 23665161 Free PMC article. Review.
-
[Mucopolysaccharidosis IVA (Morquio A syndrome): clinical, biological and therapeutic aspects].Ann Biol Clin (Paris). 2007 Jan-Feb;65(1):5-11. Ann Biol Clin (Paris). 2007. PMID: 17264033 Review. French.
Cited by
-
Oral immunotherapy tolerizes mice to enzyme replacement therapy for Morquio A syndrome.J Clin Invest. 2020 Mar 2;130(3):1288-1300. doi: 10.1172/JCI125607. J Clin Invest. 2020. PMID: 31743109 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources